Inhaled antibiotic to prevent pneumonia in brain injury patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether breathing in an antibiotic called polymyxin E can prevent pneumonia in people with brain injury who are on a breathing machine. It may help reduce lung infections in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You have a brain injury from trauma, stroke, or cardiac arrest and are in the ICU
- Your consciousness level is low (GCS score less than 12)
- You need a breathing machine for at least 48 hours
- You have not already been on the breathing machine for more than 96 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This trial tests whether inhaling an antibiotic called amikacin can prevent ventilator-associated pneumonia in patients with severe liver disease (cirrhosis) who are on a breathing machine. If you or your loved one is in the ICU with liver issues and needs a ventilator, this study may help reduce the risk of a serious lung infection.
This trial tests if inhaling a medication called colistin can prevent ventilator-associated pneumonia (a lung infection) in patients who are on a breathing machine. It aims to reduce the risk for those at high risk of getting an infection from drug-resistant bacteria.
This trial tests whether using a fast respiratory test combined with a treatment plan can help doctors choose the right antibiotics sooner for patients in the intensive care unit who get pneumonia from a breathing machine. It aims to improve treatment and reduce unnecessary antibiotics.
This trial tests if giving antibiotics based on a patient's unique gut bacteria can prevent pneumonia in people who are on a breathing machine (ventilator) in the intensive care unit (ICU). It aims to see if this personalized approach is more effective than standard care.
This trial tests if the antibiotic ceftriaxone can prevent early pneumonia in patients on breathing machines after a serious brain injury.
Hear when a new Ventilator-Associated Pneumonia (VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.